Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 11, 2024
Abstract
Despite
advances
in
the
controlled
reconfiguration
of
DNA
structures
for
biological
applications,
dearth
strategies
that
allow
orthogonal
regulation
immune
pathways
remains
a
challenge.
Here,
we
report
first
time
an
endogenous
and
exogenous
tandem‐regulated
assembly
strategy
enables
orthogonally
stimulation
cyclic
GMP‐AMP
synthase
(cGAS)‐stimulator
interferon
genes
(STING)
pathway.
A
motif
containing
two
palindromic
sequences
is
engineered
with
abasic
site
(AP)‐connected
blocking
sequence
to
inhibit
its
self‐assembly
function,
while
apurinic/apyrimidinic
endonuclease
1
(APE1)‐triggered
enzymatic
cleavage
AP
into
long
double‐stranded
structures,
thus
realizing
allosteric
activation
catalytic
activity
cGAS
produce
2’3’‐cyclic‐GMP‐AMP
STING
stimulation.
Importantly,
demonstrate
APE1‐regulated
allows
cell‐selective
cGAS–STING
signaling.
Furthermore,
by
re‐engineering
photocleavable
group,
enzyme‐triggered
operate
(switched
“ON”),
whereas
light‐mediated
fragmentation
termination
such
“OFF”),
thereby
achieving
control
over
regulation.
This
work
highlights
tandem
regulated
modulate
pathway
manner.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(36)
Published: June 14, 2024
Mitochondria,
one
of
the
most
important
organelles,
represent
a
crucial
subcellular
target
for
fundamental
research
and
biomedical
applications.
Despite
significant
advances
in
design
DNA
nanotechnologies
variety
bio-applications,
dearth
strategies
that
enable
mitochondria
targeting
molecular
imaging
therapy
remains
an
outstanding
challenge
this
field.
In
Minireview,
we
summarize
recent
progresses
on
emerging
application
nanotechnology
mitochondria-targeted
tumor
treatment.
We
first
highlight
engineering
mitochondria-localized
nanosensors
situ
detection
diverse
key
molecules
are
essential
to
maintain
mitochondrial
functions,
including
microRNA,
enzymes,
small
molecules,
metal
ions.
Then,
compile
developments
anti-tumor
therapy,
modularly
designed
nanodevices
delivery
therapeutic
agents,
programmed
assembly
interference.
will
place
emphasis
clarification
chemical
principles
how
nanobiotechnology
can
be
various
Finally,
remaining
challenges
future
directions
field
discussed,
hoping
inspire
further
development
advanced
toolkits
both
academic
clinical
regarding
mitochondria.
Chemical Communications,
Journal Year:
2024,
Volume and Issue:
60(78), P. 10805 - 10821
Published: Jan. 1, 2024
DNAzymes,
a
class
of
single-stranded
catalytic
DNA
with
good
stability,
high
activity,
and
easy
synthesis,
functionalization
modification
properties,
have
garnered
significant
interest
in
the
realm
biosensing
bioimaging.
Their
integration
fluorescent
dyes
or
chemiluminescent
moieties
has
led
to
remarkable
bioimaging
outcomes,
while
DNAzyme-based
biosensors
demonstrated
robust
sensitivity
selectivity
detecting
metal
ions,
nucleic
acids,
proteins,
enzyme
activities,
exosomes,
bacteria
microorganisms.
In
addition,
by
delivering
DNAzymes
into
tumor
cells,
mRNA
therein
can
be
cleaved
regulate
expression
corresponding
which
further
propelled
application
cancer
gene
therapy
synergistic
therapy.
This
paper
reviews
strategies
for
screening
attractive
such
as
SELEX
high-throughput
sequencing,
briefly
describes
amplification
mainly
include
hairpin
assembly
(CHA),
walker,
hybridization
chain
reaction
(HCR),
origami,
CRISPR-Cas12a,
rolling
circle
(RCA),
aptamers.
applications
bioimaging,
biosensing,
are
also
highlighted.
Subsequently,
possible
challenges
these
practical
pointed
out,
future
research
directions
suggested.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Herein,
a
supramolecular
DNA
nanodevice
was
formed
via
the
rolling
circle
amplification
(RCA)
and
hybridization
chain
reaction
(HCR)
cascade
on
tetrahedral
nanostructure
(TDN)
to
achieve
simultaneous
sensitive
detection
intracellular
imaging
of
dual-miRNAs
related
liver
cancer.
The
effectively
addressed
limitations
low
probe
loading
capacity
in
traditional
TDN
nanodevices
by
enriching
plenty
signal
probes
around
single
TDN,
significantly
enhancing
fluorescence
signal.
Impressively,
with
fulcrum
dense
structure
imparted
strong
rigidity,
ensuring
stability
decrease
aggregation
quenching
for
further
increasing
response.
Consequently,
biosensor
based
enabled
miRNA221
miRNA222,
achieved
accurate
situ
displaying
improved
capabilities
compared
TDN-based
nanodevices.
More
importantly,
precise
miRNA222
could
distinguish
hepatocellular
carcinoma
cells
different
degrees
metastasis
from
human
normal
cells,
providing
more
information
diagnosis
development
carcinoma.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 12, 2025
Developing
tumor
cell-specific
imaging
approaches
is
essential
for
the
clear
delineation
of
margins.
However,
traditional
suffered
from
low
reaction
kinetics
as
well
limited
specificity
resulting
their
"always
active"
sensing
mode,
making
it
difficult
to
accurately
depict
boundary.
To
address
these
limitations,
we
developed
an
endogenous
enzyme-activated
spatial
confinement
DNA
nanowire
probe
(E-SCNW)
with
enhanced
tumor/normal
cell
discrimination
ratio
high
precision
cells
The
effect
can
improve
kinetics,
and
enzyme-activation
design
confine
fluorescence
response
region.
Additionally,
no
additional
delivery
carriers
were
required
during
cross
membrane
into
intracellular
space.
It
worth
noting
that
benefiting
design,
detection
limit
was
decreased
by
nearly
25.6-fold
4.46-fold
through
using
E-SCNW,
indicating
promising
prospects
in
high-precision
Critical Reviews in Food Science and Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 20
Published: April 6, 2025
DNAzyme-based
biosensors
have
emerged
as
a
promising
tool
for
ensuring
food
safety
due
to
their
high
sensitivity,
specificity,
and
potential
rapid,
cost-effective
detection
of
hazardous
substances.
These
leverage
DNAzymes-catalytically
active
DNA
molecules-to
detect
range
contaminants,
including
metal
ions,
fungal
toxins,
pesticides,
pathogens.
While
show
significant
advantages
over
conventional
techniques,
challenges
such
nuclease
degradation,
interference
from
complex
sample
matrices,
the
costs
associated
with
DNAzyme
synthesis
still
hinder
widespread
application.
Recent
advancements
in
stability
DNAzymes,
immobilization
strategies,
integration
nanomaterials
are
progressively
addressing
these
limitations,
enhancing
performance
reliability
sensors.
This
review
highlights
structural
catalytic
characteristics
assesses
current
applications
safety,
discusses
innovative
strategies
overcome
existing
challenges.
The
continuous
evolution
biosensors,
particularly
design
device
integration,
holds
great
promise
future
role
routine,
reliable
analysis.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
136(36)
Published: June 14, 2024
Abstract
Mitochondria,
one
of
the
most
important
organelles,
represent
a
crucial
subcellular
target
for
fundamental
research
and
biomedical
applications.
Despite
significant
advances
in
design
DNA
nanotechnologies
variety
bio‐applications,
dearth
strategies
that
enable
mitochondria
targeting
molecular
imaging
therapy
remains
an
outstanding
challenge
this
field.
In
Minireview,
we
summarize
recent
progresses
on
emerging
application
nanotechnology
mitochondria‐targeted
tumor
treatment.
We
first
highlight
engineering
mitochondria‐localized
nanosensors
situ
detection
diverse
key
molecules
are
essential
to
maintain
mitochondrial
functions,
including
microRNA,
enzymes,
small
molecules,
metal
ions.
Then,
compile
developments
anti‐tumor
therapy,
modularly
designed
nanodevices
delivery
therapeutic
agents,
programmed
assembly
interference.
will
place
emphasis
clarification
chemical
principles
how
nanobiotechnology
can
be
various
Finally,
remaining
challenges
future
directions
field
discussed,
hoping
inspire
further
development
advanced
toolkits
both
academic
clinical
regarding
mitochondria.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
96(28), P. 11397 - 11403
Published: June 28, 2024
Low-mass
soluble
β-amyloid
peptide
oligomers
(LSAβOs)
play
a
crucial
role
in
the
pathogenesis
of
Alzheimer's
disease.
However,
these
exhibit
heterogeneity
terms
structure,
stability,
and
stoichiometry,
their
abundance
biofluids
is
low,
making
accurate
identification
challenging.
In
this
study,
we
developed
DNA
nanocage-assisted
method
for
selective
sizing
sensitive
quantification
LSAβOs
serum.
Using
LSAβO
less
than
10
kDa
(LSAβO10kD)
30
(LSAβO30kD)
as
models,
size-matching
rules
between
nanocages
were
investigated,
two
appropriate
selected
detection
LSAβOs,
respectively.
Both
functionalized
by
encapsulating
oligomer's
aptamer
complementary
sequence
within
cavities.
Once
entered
corresponding
nanocage
cavity,
was
released,
triggering
hybridization
chain
reaction
on
an
electrochemical
sensing
platform.
The
system
achieved
size-selective
discrimination
LSAβO10kD
with
linear
range
10–150
pM
LSAβO30kD
15–150
pM.
Real
sample
testing
confirmed
applicability
blood-based
diagnosis.
analysis
platform
provides
accurate,
highly
selective,
approach
oligomer
analysis,
which
significant
amyloid
protein
research
related
disease
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 29, 2024
Abstract
Despite
the
significant
potential
of
RNA‐cleaving
DNAzymes
for
gene
regulation,
their
application
is
limited
by
low
therapeutic
efficacy
and
lack
cell‐specific
control.
Here,
a
DNAzyme‐based
nanohybrid
designed
ultrasound
(US)‐controlled,
enzyme‐activatable
mRNA
regulation
presented,
enabling
tumor
cell‐selective
combination
therapy.
The
constructed
coordination‐directed
self‐assembly
an
enzymatically‐triggerable
DNAzyme
(En‐Dz)
natural
sonosensitizer
hemoglobin
(Hb).
Controlled
US
exposure
induces
reactive
oxygen
species
generation
from
Hb
units,
which
not
only
facilitates
efficient
endosomal
escape
En‐Dz,
but
also
promotes
translocation
specific
enzyme
nucleus
to
cytoplasm,
thereby
enhancing
efficacy.
Notably,
enzyme‐triggered,
spatiotemporally‐controlled
activation
En‐Dz's
catalytic
activity
results
in
enhanced
cancer‐cell
selectivity
treatment.
Furthermore,
enzyme‐activated
sonodynamic
therapy
significantly
enhances
anti‐tumor
both
vitro
vivo.
This
work
highlights
integrating
strategy
overcome
current
limitations
regulators,
providing
approach
precise